- Home
- CLVT vs OCUL Comparison
CLVT vs OCUL Comparison
Compare CLVT & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLVT | OCUL |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United Kingdom | United States |
| Employees | 12000 | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | CLVT | OCUL |
|---|---|---|
| Price | $2.54 | $9.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $3.22 | ★ $23.56 |
| AVG Volume (30 Days) | ★ 4.6M | 2.7M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,990,000.00 |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | $2.12 | $96.07 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 3.48 |
| 52 Week Low | $1.66 | $6.23 |
| 52 Week High | $4.77 | $16.44 |
Technical Indicators
Market Signals| Indicator | CLVT | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 52.62 |
| Support Level | $2.35 | $9.06 |
| Resistance Level | $2.70 | $9.93 |
| Average True Range (ATR) | 0.15 | 0.43 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 38.53 | 64.44 |
Price Performance
Historical ComparisonAbout CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.